Tool | Page 8 of 46 | SpiritIndia.com

Blood :: American College of Medical Genetics responds to new FDA labeling decision for warfarin

On August 16, the Food and Drug Administration approved new labeling information for the blood-thinner warfarin, sold under the brand name Coumadin. The new label suggests that one can prescribe higher or lower doses that may be safer for patients with variations in two genes, CYP2C9 or VKORC1. These variations can be learned through genetic testing, which may be a useful tool in determining appropriate dosing levels for individual patients and lower risks of bleeding complications.

Tumor :: Novel 3-D cell culture model shows selective tumor uptake of nanoparticles

A nanoparticle drug delivery system designed for brain tumor therapy has shown promising tumor cell selectivity in a novel cell culture model devised by University of Nottingham scientists. The project, conducted jointly in the Schools of Pharmacy, Biomedical Sciences and Human Development, will be featured in the September issue of the Experimental Biology and Medicine.

Brain :: Researchers discover noninvasive diagnostic tool for brain diseases

Researchers from the University of Minnesota Medical School and Brain Sciences Center at the Minneapolis VA Medical Center have identified a noninvasive and painless way to diagnose complex brain diseases.

Vitamin D :: Benefit of vitamin D in fighting cancer

A new study looking at the relationship between vitamin D serum levels and the risk of colon and breast cancer across the globe has estimated the number of cases of cancer that could be prevented each year if vitamin D3 levels met the target proposed by researchers.

Pollution :: Province supports air quality health index

The B.C. government has invested $100,000 into a BC Lung Association public education campaign that uses the Air Quality Health Index (AQHI) to better inform British Columbians about air pollution levels, Environment Minister Barry Penner said today.

Medicine :: Shire supports Canada’s Access to Medicines Regime

Shire BioChem Inc. announced that it is pleased to support Canada?s Access to Medicines Regime to enable a Canadian company (Apotex) to manufacture in Canada a generic fixed dose triple combination antiretroviral medicine that contains a drug (3TC?) over which Shire BioChem Inc. holds patent rights in Canada.

Cancer :: New computer software helps GPs spot family cancer risk

The use of ‘decision support’ computer software can significantly improve the management of patients concerned about their family history of breast and bowel cancer, according to a study published in the British Journal of Cancer* today (Tuesday).

Anthrax :: Anthrax vaccine produces immunity with nanoparticles, not needles

A vaccine against anthrax that is more effective and easier to administer than the present vaccine has proved highly effective in tests in mice and guinea pigs, report University of Michigan Medical School scientists in the August issue of Infection and Immunity.

Prostate Cancer :: First biomarker discovered that predicts prostate cancer outcome

Mayo Clinic researchers have identified the first immune molecule that appears to play a role in prostate cancer development and in predicting cancer recurrence and progression after surgery. The report on the B7-H3 molecule by Mayo Clinic Cancer Center appears today in Cancer Research.

Eyes :: Bubble-based technology to test, treat eyes

By bouncing sound waves off tiny bubbles generated inside eye tissue, a biomedical engineer at The University of Texas at Austin is developing a new tool that could improve the outcome of laser eye surgery and address common eye conditions.